-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, V3bQagRf803eha2yFA1MVXKfWo9rd09dzZBMz9pme3Uy3iCORsI0QjtbPUx8KXFR fIpn9XGDpxNKOwzgghcLVg== 0001209191-05-039460.txt : 20050729 0001209191-05-039460.hdr.sgml : 20050729 20050729175415 ACCESSION NUMBER: 0001209191-05-039460 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050714 FILED AS OF DATE: 20050729 DATE AS OF CHANGE: 20050729 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TARGETED GENETICS CORP /WA/ CENTRAL INDEX KEY: 0000921114 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911549568 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1100 OLIVE WAY STREET 2: STE 100 CITY: SEATTLE STATE: WA ZIP: 98101 BUSINESS PHONE: 2066237612 MAIL ADDRESS: STREET 1: 1100 OLIVE WAY STREET 2: STE 100 CITY: SEATTLE STATE: WA ZIP: 98101 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BIOGEN IDEC MA INC CENTRAL INDEX KEY: 0000714655 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-23930 FILM NUMBER: 05986098 BUSINESS ADDRESS: STREET 1: 14 CAMBRIDGE CTR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-679-2000 MAIL ADDRESS: STREET 1: 14 CAMBRIDGE CTR CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER NAME: FORMER CONFORMED NAME: BIOGEN INC DATE OF NAME CHANGE: 19920703 FORMER NAME: FORMER CONFORMED NAME: BIOGEN NV DATE OF NAME CHANGE: 19880622 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BIOGEN IDEC INC CENTRAL INDEX KEY: 0000875045 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-23930 FILM NUMBER: 05986099 BUSINESS ADDRESS: STREET 1: 11011 TORREYANA ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6195508500 MAIL ADDRESS: STREET 1: 11011 TORREYANA ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER NAME: FORMER CONFORMED NAME: IDEC PHARMACEUTICALS CORP / DE DATE OF NAME CHANGE: 19970530 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0202 4/A 2005-07-14 2005-07-18 0 0000921114 TARGETED GENETICS CORP /WA/ TGEN 0000875045 BIOGEN IDEC INC 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142 0 0 1 0 0000714655 BIOGEN IDEC MA INC 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142 0 0 1 0 Common Stock, $0.01 Par Value 2005-07-14 4 S 0 8000 0.79 D 12094178 I by Biogen Idec MA, Inc. Common Stock, $0.01 Par Value 2005-07-14 4 S 0 500 0.7902 D 12093678 I by Biogen Idec MA, Inc. Common Stock, $0.01 Par Value 2005-07-14 4 S 0 1000 0.791 D 12092678 I by Biogen Idec MA, Inc. Common Stock, $0.01 Par Value 2005-07-14 4 S 0 15268 0.80 D 12077410 I by Biogen Idec MA, Inc. Common Stock, $0.01 Par Value 2005-07-14 4 S 0 232 0.81 D 12077178 I by Biogen Idec MA, Inc. Common Stock, $0.01 Par Value 2005-07-15 4 S 0 33550 0.80 D 12043628 I by Biogen Idec MA, Inc. Common Stock, $0.01 Par Value 2005-07-15 4 S 0 3000 0.8002 D 12040628 I by Biogen Idec MA, Inc. Common Stock, $0.01 Par Value 2005-07-15 4 S 0 1750 0.8003 D 12038878 I by Biogen Idec MA, Inc. Common Stock, $0.01 Par Value 2005-07-15 4 S 0 4000 0.801 D 12034878 I by Biogen Idec MA, Inc. Common Stock, $0.01 Par Value 2005-07-15 4 S 0 1800 0.81 D 12033078 I by Biogen Idec MA, Inc. Common Stock, $0.01 Par Value 2005-07-15 4 S 0 100 0.82 D 12032978 I by Biogen Idec MA, Inc. Common Stock, $0.01 Par Value 2005-07-18 4 S 0 2500 0.801 D 12030478 I by Biogen Idec MA, Inc. Common Stock, $0.01 Par Value 2005-07-18 4 S 0 2932 0.81 D 12027546 I by Biogen Idec MA, Inc. This amendment to the Form 4 originally filed on July 18, 2005 (the "Original Form 4") amends and restates the Original Form 4 in its entirety and is being filed to report the dispositions by the reporting person of Targeted Genetics Corporation stock on July 14, 2005 and to correct the amount of Targeted Genetics Corporation common stock beneficially owned by the reporting person. The Original Form 4 inadvertently did not include the dispositions of Target Genetics stock on July 14, 2005 and, by doing so, overreported the reporting person's beneficial ownership of Targeted Genetics Corporation common stock by 25,000 shares. Shares are owned indirectly by Biogen Idec Inc. and directly by its wholly-owned subsidiary Biogen Idec MA Inc., fka Biogen, Inc. Raymond G. Arner, Acting General Counsel, Biogen Idec Inc. 2005-07-29 Michael F. Phelps, Treasurer, Biogen Idec MA, Inc. 2005-07-29 -----END PRIVACY-ENHANCED MESSAGE-----